Calendar Minerva Surgical, Inc.

Equities

UTRS

US60343F2056

Delayed OTC Markets 12:03:47 2024-03-27 pm EDT 5-day change 1st Jan Change
0.635 USD +15.45% Intraday chart for Minerva Surgical, Inc. +7.63% -45.73%

Chart calendar Minerva Surgical, Inc.

113338c76dfac7237452b7a1f12f7966.HzLzHNYajZfLaXUNRQ0iVBDBv2FfsKq5lmHBnHda6qk.bgW3UpNV99OPDAV6DGJgJUL04BYe3O7d_AaX3U4RktFsVqdO4Dfv9K46Hg~7f3664120e15ae85116dca7d45c705ad

Upcoming events on Minerva Surgical, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)

Past events on Minerva Surgical, Inc.

2024-03-04 Q4 2023 Earnings Release (Projected)
2023-11-13 04:01 pm Q3 2023 Earnings Release
2023-09-12 12:00 am H.C. Wainwright Global Investment Conference
2023-08-02 04:30 pm Q2 2023 Earnings Call
2023-08-02 04:01 pm Q2 2023 Earnings Release
2023-05-02 04:30 pm Q1 2023 Earnings Call
2023-05-02 04:01 pm Q1 2023 Earnings Release
2023-03-21 04:30 pm Q4 2022 Earnings Call
2023-03-21 04:01 pm Q4 2022 Earnings Release
2023-02-07 12:00 pm Extraordinary Shareholder Meeting
2023-01-12 12:45 pm JP Morgan Healthcare Conference
2022-11-30 11:00 am Piper Sandler Healthcare Conference
2022-11-14 04:30 pm Q3 2022 Earnings Call
2022-11-14 04:01 pm Q3 2022 Earnings Release
2022-09-12 07:00 am H.C. Wainwright Global Investment Conference
2022-08-09 04:30 pm Interim 2022 Earnings Call
2022-08-09 04:01 pm Interim 2022 Earnings Release
2022-06-09 12:00 pm Annual General Meeting
2022-05-25 07:45 am UBS Global Healthcare Conference
2022-05-24 07:00 am H.C. Wainwright Global Life Sciences Investment Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
37,8


52,1
51,8
0.68%
50,3
50,7
-0.84%
EBITDA
Million USD
Released
Forecast
Spread
0,00


-29,1
-30,0
2.85%
-22,3
-19,3
-15.6%
EBIT
Million USD
Released
Forecast
Spread
0,00


-29,1
-30,4
4.19%
-30,9
-30,0
-2.96%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-21,5
-40,2
46.57%
-34,1
-32,5
-5.09%
Net income
Million USD
Released
Forecast
Spread
-18,3


-21,5
-39,9
46.27%
-34,1
-32,5
-5.12%
EPS
USD
Released
Forecast
Spread
0,00


-61,2
-54,0
-13.37%
-23,6
-22,6
-4.42%
Announcement Date27/09/2108/03/2222/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales
Million USD
Released
Forecast
Spread
12,5
12,1
2.94%
13,6
13,4
1.46%
10,9
10,8
1.65%
13,0
13,4
-3.34%
12,6
12,6
-0.19%
13,8
14,6
-5.41%
12,5
11,7
6.93%
13,4
13,9
-3.81%
12,0
13,2
-9.4%
EBITDA
Million USD
Released
Forecast
Spread
-2,59
-4,85
46.65%
-6,65
-8,00
16.83%
-10,3
-9,00
-14.44%
-4,90
-9,00
45.57%
-5,84
-6,08
3.85%
-5,67
-4,66
-21.69%
-6,53
-5,43
-20.28%
-4,58
-6,28
27.09%
-3,82
-6,41
40.38%
EBIT
Million USD
Released
Forecast
Spread
-6,14
-6,93
11.42%
-6,65
-8,02
17.06%
-10,3
-8,82
-16.83%
-4,90
-9,34
47.55%
-10,5
-7,58
-38.72%
-5,19
-7,66
32.23%
-10,3
-7,97
-29.36%
-7,66
-8,56
10.56%
-6,10
-8,19
25.55%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,23
-12,2
73.53%
10,8
-7,52
243.8%
-10,9
-9,59
-13.9%
-5,61
-10,2
45.14%
-11,3
-7,70
-47.13%
-6,23
-8,21
24.08%
-11,3
-8,47
-33.92%
-8,64
-9,06
4.63%
-7,18
-8,69
17.38%
Net income
Million USD
Released
Forecast
Spread
-3,23
-12,2
73.53%
10,8
-7,52
243.68%
-10,9
-9,15
-19.36%
-5,61
-10,2
45.14%
-11,3
-7,70
-47.13%
-6,23
-8,21
24.08%
-11,3
-8,47
-33.92%
-8,68
-9,06
4.2%
-7,18
-8,69
17.35%
EPS
USD
Released
Forecast
Spread
-2,24
-8,51
73.68%
7,50
-5,68
231.94%
-7,60
-6,19
-22.7%
-4,00
-6,79
41.11%
-8,00
-5,56
-43.9%
-4,00
-5,60
28.57%
-2,40
-2,20
-9.09%
-1,00
-1,80
44.44%
-0,81
-1,00
19%
Announcement Date02/12/2108/03/2211/05/2209/08/2214/11/2222/03/2302/05/2302/08/2313/11/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise